Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model
2007

Daily Dosing of Rifapentine Cures Tuberculosis in Three Months or Less in Mice

Sample size: 40 publication 10 minutes Evidence: high

Author Information

Author(s): Ian M. Rosenthal, Ming Zhang, Kathy N. Williams, Charles A. Peloquin, Sandeep Tyagi, Andrew A. Vernon, William R. Bishai, Richard E. Chaisson, Jacques H. Grosset, Eric L. Nuermberger

Primary Institution: Johns Hopkins University School of Medicine

Hypothesis

Can existing drugs be used more effectively to shorten the treatment duration for tuberculosis?

Conclusion

Daily and thrice-weekly administration of rifapentine and moxifloxacin can cure tuberculosis in mice in three months or less.

Supporting Evidence

  • Mice treated with rifapentine and moxifloxacin had negative lung cultures after 2 months.
  • Standard treatment required 6 months to achieve similar results.
  • No relapses were observed in mice treated with the new regimen after 3 months.

Takeaway

Researchers found that giving mice a combination of two drugs every day or three times a week can cure tuberculosis much faster than the usual treatment.

Methodology

Mice infected with tuberculosis were treated with different drug regimens, and their lung cultures were monitored for bacterial growth.

Potential Biases

Potential bias in extrapolating results from mice to humans.

Limitations

Results are based on a murine model, which may not fully predict human responses.

Participant Demographics

Mice (BALB/c strain) were used in the study.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1371/journal.pmed.0040344

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication